CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)
US:NASDAQ Investor Relations:
collplant.com/investor-relation
Company Research
Source: Yahoo! Finance
Cost of Revenues (Q3 2024): $272,000 compared to $278,000 in Q3 2023. Gross Loss (Q3 2024): $268,000 compared to $235,000 in Q3 2023. Operating Expenses (Q3 2024): $4.3 million compared to $4.4 million in Q3 2023. Net Loss (Q3 2024): $4.3 million or $0.38 per share compared to $4.4 million or $0.38 per share in Q3 2023. Cash and Cash Equivalents (September 30, 2024): $15.4 million. Cash Used in Operating Activities (Nine Months Ended September 30, 2024): $10.6 million compared to $418,000 in the same period of 2023. Warning! GuruFocus has detected 4 Warning Signs with CLGN. Release Date: November 27, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript CollPlant Biotechnologies Ltd ( NASDAQ:CLGN ) has advanced its preclinical study for regenerative breast implants, showing promising results in implant vascularization and tissue ingrowth. The company's proprietary rhCollagen technology is highly characterized and
Show less
Read more
Impact Snapshot
Event Time:
CLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLGN alerts
High impacting CollPlant Biotechnologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLGN
News
- CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.MarketBeat
- CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
- COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]Yahoo! Finance
- COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR Newswire
- What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
CLGN
Earnings
- 11/27/24 - Beat
CLGN
Analyst Actions
- 11/29/24 - HC Wainwright
CLGN
Sec Filings
- 11/27/24 - Form 6-K
- 9/25/24 - Form 6-K
- CLGN's page on the SEC website